Brief: Almirall Divests Its Actithiol Franchise for €15 Mln
30/06/2026 10:55
BRIEF-Almirall Divests Its Actithiol Franchise for €15 Mln June 30 (Reuters) - Almirall SA ALM.MC:
DIVESTS ITS ACTITHIOL FRANCHISE
DIVESTMENT INCLUDES ACTITHIOL ANTIHISTAMÍNICO, ACTITHIOL PEDIÁTRICO, AND MUCOACTIOL
DEAL VALUE IS EUR 15 MILLION WITH EUR 13 MILLION UPFRONT AND EUR 2 MILLION MILESTONE PAYMENTS
Source text
Further company coverage: ALM.MC
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Almirall
See all newsBrief: Almirall Says Phase 3B Adlong Clinical Study Show Treatment Outcomes With Up To Five Years Of Lebrikizumab
Brief: Almirall And CrystalO To Discover, Develop Novel Small Molecules In Medical Dermatology
Almirall shares rise as lower costs beat EBITDA estimates
Brief: Almirall, Certest Biotec Sign Deal to Develop Rare Dermatology Treatments
Spanish stocks - Factors to watch on July 24